NAGE Niagen Bioscience, Inc.

NASDAQ
$1.94

Niagen Bioscience, Inc. (NAGE) Earnings News

Earnings press releases, previews and reviews for Niagen Bioscience, Inc. (NAGE), newest first. Our most recent is review: Niagen Bioscience Matches on EPS, but a 20% Revenue Drop and Fading Guidance Push the Story to 2027.